You shouldnt take tirzepatide medications or Wegovy if you have: A personal or family history of medullary thyroid carcinoma (MTC) A history of multiple endocrine neoplasia syndrome type 2 (MEN 2) A serious allergic reaction to tirzepatide, semaglutide , or any of the ingredients in these medications Your clinician will determine if GLP-1 medications are right for you if you have a history of: Pancreatitis , kidney problems, or gallbladder disease, including gallstones Diabetic retinopathy Gastroparesis or other serious digestive conditions Tirzepatide and Wegovy are also not for people who are pregnant, planning to become pregnant, or breastfeeding
Patients typically see significant changes within the first month, with continued progress over 3-6 months
However, in patients aged 85 years and over, the ADA guidelines recommend a target of 130/80 for the healthy ones and those with few complications and 140/90 for those with very complex conditions, or bad health status [78]
No randomized controlled trials have evaluated the combination of NAD+ precursors with tirzepatide or similar medications
